Renal/JJ
cell/NN
carcinoma-derived/JJ
gangliosides/NNS
suppress/VBP
nuclear/JJ
factor-kappaB/NN
activation/NN
in/IN
T/NN
cells/NNS
./.

Activation/NN
of/IN
the/DT
transcription/NN
factor/NN
nuclear/JJ
factor-kappaB/NN
(/(
NFkappaB/NN
)/)
is/VBZ
impaired/JJ
in/IN
T/NN
cells/NNS
from/IN
patients/NNS
with/IN
renal/JJ
cell/NN
carcinomas/NNS
(/(
RCCs/NNS
)/)
./.
=====
In/IN
circulating/VBG
T/NN
cells/NNS
from/IN
a/DT
subset/NN
of/IN
patients/NNS
with/IN
RCCs/NNS
,/,
the/DT
suppression/NN
of/IN
NFkappaB/NN
binding/NN
activity/NN
is/VBZ
downstream/JJ
from/IN
the/DT
stimulus-induced/JJ
degradation/NN
of/IN
the/DT
cytoplasmic/JJ
factor/NN
IkappaBalpha/NN
./.
=====
Tumor-derived/JJ
soluble/JJ
products/NNS
from/IN
cultured/VBN
RCC/NN
explants/NNS
inhibit/VBP
NFkappaB/NN
activity/NN
in/IN
T/NN
cells/NNS
from/IN
healthy/JJ
volunteers/NNS
,/,
despite/IN
a/DT
normal/JJ
level/NN
of/IN
stimulus-induced/JJ
IkappaBalpha/NN
degradation/NN
in/IN
these/DT
cells/NNS
./.
=====
The/DT
inhibitory/JJ
agent/NN
has/VBZ
several/JJ
features/NNS
characteristic/JJ
of/IN
a/DT
ganglioside/NN
,/,
including/VBG
sensitivity/NN
to/TO
neuraminidase/NN
but/CC
not/RB
protease/NN
treatment/NN
;/:
hydrophobicity/NN
;/:
and/CC
molecular/JJ
weight/NN
less/JJR
than/IN
3/CD
kDa/NN
./.
=====
Indeed/RB
,/,
we/PRP
detected/VBD
gangliosides/NNS
in/IN
supernatants/NNS
from/IN
RCC/NN
explants/NNS
and/CC
not/RB
from/IN
adjacent/JJ
normal/JJ
kidney/NN
tissue/NN
./.
=====
Gangliosides/NNS
prepared/VBN
from/IN
RCC/NN
supernatants/NNS
,/,
as/RB
well/RB
as/IN
the/DT
purified/VBN
bovine/NN
gangliosides/NNS
G/NN
(/(
m1/NN
)/)
and/CC
G/NN
(/(
d1a/NN
)/)
,/,
suppressed/VBD
NFkappaB/NN
binding/NN
activity/NN
in/IN
T/NN
cells/NNS
and/CC
reduced/VBD
expression/NN
of/IN
the/DT
cytokines/NNS
IL-2/NN
and/CC
IFN-gamma/NN
./.
=====
Taken/VBN
together/RB
,/,
our/PRP$
findings/NNS
suggest/VBP
that/IN
tumor-derived/JJ
gangliosides/NNS
may/MD
blunt/VB
antitumor/JJ
immune/JJ
responses/NNS
in/IN
patients/NNS
with/IN
RCCs/NNS
./.